<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig4">
 <label>Fig. 4</label>
 <caption>
  <p>Effect of sertraline treatment on the function of calvarial cell populations. 
   <bold>a</bold>–
   <bold>d</bold> Effect of sertraline on the proliferative potential of cell types within the defect site. 
   <bold>e</bold>–
   <bold>h</bold> Apoptotic effect of sertraline. 
   <bold>i</bold>–
   <bold>l</bold> ALP function of cell types within the defect site after sertraline treatment. 
   <bold>b</bold> Pre-osteoblast E1s were shown to have significantly decreased proliferation after sertraline treatment for 3 days, while by 7 days, a significant increase was observed (
   <italic>P</italic> &lt; 0.001). In comparison, 
   <bold>e</bold>–
   <bold>h</bold> the apoptotic effect of sertraline was shown to significantly decrease for 
   <bold>f</bold> BMSCs (
   <italic>P</italic> &lt; 0.01) and 
   <bold>g</bold> E1s (
   <italic>P</italic> &lt; 0.01), with 
   <bold>e</bold> C2C12s and 
   <bold>h</bold> primary calvarial cells also showing trends toward decreased apoptosis with sertraline treatment compared to control. Sertraline was found to significantly decrease 
   <bold>i</bold> C2C12 (
   <italic>P</italic> &lt; 0.001) and 
   <bold>j</bold> BMSC (
   <italic>P</italic> &lt; 0.001) ALP production at 7 days. 
   <italic>n</italic> = 2–6 per cell type. 
   <sup>#</sup> different from control; * different from low-dose sertraline; *
   <italic>P</italic> &lt; 0.05; **
   <italic>P</italic> &lt; 0.01. Data are means ± standard errors
  </p>
 </caption>
 <graphic xlink:href="41368_2018_26_Fig4_HTML" id="d29e1014" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
